New Drug for Metastatic Melanoma Shows Promising Results in Clinical Trial, Vanderbilt University Medical Center Reveals  
11/11/2010 6:58:33 AM -- A clinical trial of a promising new experimental therapy for metastatic melanoma has shown positive results, including tumor shrinkage in the majority of patients. The positive results support previously reported positive data for the drug known as PLX4032 (RG7204) in a much larger patient population where all responses were confirmed by an independent review committee.